Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 and Childhood Cancer - Diagnostic Delay, Survival, and COVID-19 Susceptibility

NCT06482281 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06482281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 and Childhood Cancer - Diagnostic Delay, Survival, and COVID-19 Susceptibility
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2023
Completion date
December 31, 2025
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood cancer, childhood leukemia, acute lymphoblastic, covid-19